T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment
Saskia J.A.M. Santegoets, Anita G.M. Stam, Sinéad M. Lougheed, Helen Gall, Petra E.T. Scholten, Martine Reijm, Karin Jooss, Natalie Sacks, Kristen Hege, Israel Lowy, Jean Marie Cuillerot, B. Mary E. Von Blomberg, Rik J. Scheper, Alfons J.M. Van Den Eertwegh, Winald R. Gerritsen, Tanja D. De Gruijl
Research output: Contribution to journal › Article › peer-review
79Scopus
citations
Fingerprint
Dive into the research topics of 'T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment'. Together they form a unique fingerprint.